Recent Headlines
Alventa Pharma Pvt. Ltd. Introduces Affordable Generic Pharmaceutical Drugs and Extends Contract Manufacturing Services
India-based Alventa Pharma, a leading third party manufacturing pharma, is excited to announce the launch of their cost-effective generic drugs in both domestic and international markets. Alongside being Third party manufacturing pharma, Alventa Pharma now expands its services as a contract... - June 21, 2023 - Alventa Pharma Limited
PharmStars Announces Spring 2023 Accelerator Graduates: 13 Digital Health Startups Complete PharmStars’ Pharma-Focused Accelerator Program
PharmStars, the pharma-focused accelerator for digital health startups, announces that 13 startups have graduated from its Spring 2023 program focused on “Innovations in Women’s Health or Health Equity.” The graduating startups successfully completed PharmaU, PharmStars’ 10-week program. PharmaU culminated with a Showcase Event, held in Boston in May, that brought together the participating startups and PharmStars’ innovation-minded pharma members. - June 20, 2023 - PharmStars
ALPCO Receives FDA 510(k) Clearance for the Calprotectin Immunoturbidimetric Assay
American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, today announced recent FDA 510(k) clearance of its Calprotectin Immunoturbidimetric Assay. The Calprotectin Immunoturbidimetric (IT) Assay is now IVDD and 510(k)-cleared for in... - June 15, 2023 - ALPCO
PharmStars Announces “Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface” Theme for its Fall 2023 Accelerator
PharmStars, the pharma-focused accelerator for digital health startups, is accepting applications for its Fall 2023 cohort around the theme “Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface.” The cohort is open to startups with digital health solutions that pharma can use to innovate therapeutic supply chain management, medication delivery, or the patient-drug experience for small molecules, biologics, or advanced therapies. Applications are due July 10, 2023. - June 06, 2023 - PharmStars
GenInvo Part of PHUSE US Connect & Informa Connect Clinical Data Disclosure, Transparency & Plain Language Summaries Event - 2023
GENINVO was a part of 2 recent global events for the life science industry. The first was "PHUSE US Connect 2023" which was held in Renaissance Orlando at SeaWorld Florida on 5th – 8th March 2023 and the second event, Informa Connect Clinical Data Disclosure, Transparency &... - June 05, 2023 - GenInvo, Inc.
Opening New Frontiers in Oral Care and the Cannabinoid Market
A groundbreaking patent has been unveiled, presenting a revolutionary method for the prevention and treatment of dental pulp-associated diseases using a cannabinoid-based composition. This patent offers pharmaceutical companies a unique opportunity to enter the rapidly growing cannabinoid market while addressing critical dental care needs. - June 04, 2023 - CannIBite
New Research Benchmarks Biopharmaceutical Perceptions of Global CRO Thought Leadership
Landmark Research Analyzes Perspectives of US and EU Biopharma C-Suite, Clinical Operations and Medical/Regulatory Affairs Professionals on Global CRO Thought Leadership. - June 01, 2023 - Life Science Strategy Group, LLC
Huntington Study Group Announces Call for Abstracts for 30th Annual Meeting
The Huntington Study Group (HSG), with a mission of accelerating treatments that make a difference for those impacted by Huntington’s disease, together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease... - June 01, 2023 - Huntington Study Group
OPTI•MIST® Introduces Innovative Organic Personal Care Products
OPTI•MIST® Organic Introduces Innovative Organic Personal Care Products Infused with a Powerful Mineral-Based Antiseptic for Enhanced Hygiene. OPTI•MIST, a pioneering brand in the personal care industry, is pleased to announce the launch of its revolutionary line of organic personal... - May 26, 2023 - OPTI-LAB INC.
The Inc. Magazine, USA Includes Paras Biopharma (Biologics CDMO) as One of the Top 10 Most Innovative Biotech Companies to Follow in 2023
Paras Biopharma (Biologics CDMO), a biopharmaceutical technology development company is pleased to be included by The Inc. Magazine, USA as “One of the Top 10 Most Innovative Biotech Companies to Follow in 2023.” The Inc. Magazine serves as an online "go-to" informative tool for business leaders and entrepreneurs, including CEOs and owners of small-to-midsize companies to success, providing news, advice, and inspirational articles. - May 19, 2023 - Paras Biopharmaceuticals Finland Oy
Neurocrine Biosciences Announces Publication of Full KINECT™-HD Phase 3 Study Results of Valbenazine
Neurocrine Biosciences Announces Publication of Full KINECT™-HD Phase 3 Study Results of Valbenazine for the Treatment of Chorea Associated with Huntington’s Disease in The Lancet Neurology. - Statistically Significant Improvement in Chorea Associated with Huntington’s Disease... - May 19, 2023 - Huntington Study Group
PharmStars Announces Spring 2023 Startup Showcase Event Underway
PharmStars, the pharma-focused accelerator for digital health startups, announces that its fourth Showcase Event begins May 16, 2023. The Showcase is the culmination of the Spring 2023 10-week accelerator program. At the Showcase, each startup in the fourth cohort makes a formal presentation to and meets individually with PharmStars’ pharma members. The theme of the Spring 2023 program is digital innovations in women’s health or health equity. - May 16, 2023 - PharmStars
Huntington Study Group Achieves Last Patient Last Visit for Its Observational Study to Test Virtual Use of the Unified Huntington’s Disease Rating Scale®
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., announces an important milestone in the novel observational study Virtual Unified Huntington’s Disease Rating Scale (vUHDRS™). The last participant completed the last visit, marking... - May 16, 2023 - Huntington Study Group
Parvus Therapeutics Announces a Publication Describing the Cellular Origin of Treg Cells Generated Endogenously by Navacim Therapy
Parvus Therapeutics announced today the publication of data showing that peptide-MHC class II-coated nanoparticles (Navacims) operate by triggering the expansion of cognate T follicular helper (TFH) cells. - May 09, 2023 - Parvus Therapeutics U.S., Inc.
New Traceable Opioid Material® Kit Expands Coverage to Other Emerging Drugs of Concern in Seized Samples and Toxicological Casework
Cayman Chemical and the Centers for Disease Control and Prevention (CDC) have released a new addition to the Traceable Opioid Material® Kits (TOM Kits®) product line that expands testing laboratory capabilities beyond synthetic opioids to include additional emerging drugs of abuse that are commonly found as co-drugs in fentanyl-containing samples. - April 30, 2023 - Cayman Chemical Company
Liberum Independent Medical Education Announces Management Buyout
Liberum Independent Medical Education, provider of independent medical education (IME) to healthcare professionals worldwide, has announced a management buyout (MBO) from its original owner, OHC London Holdings Ltd. The MBO was led by the company's Managing Director, Celeste Kolanko who has taken ownership of the company which now operates as Liberum IME BV, and Liberum Independent Medical Education Ltd. - April 29, 2023 - Liberum Independent Medical Education Ltd
How to Select the Right Load Movement System - Podcast Now Available
AeroGo, manufacturer of innovative load moving equipment, launched a new seven-episode podcast, called, "Select the Right Load Movement System." Each episode covers a specific question used to narrow down the choices available to the listener’s situation. - April 26, 2023 - AeroGo, Inc.
Johari Digital Makes a Significant Contribution from Their CSR Fund to Support Innovation, Research & Incubation at IIT, Jodhpur
As a part of the Industry and Academia collaboration, Johari Digital Healthcare Ltd. donated a significant funding amount to IIT, Jodhpur Incubation & Innovation center from their CSR Fund to boost & strengthen Med-Tech Startup Ecosystem. Mr. Satyendra Johari, Executive Chairman &... - April 24, 2023 - Johari Digital Healthcare Ltd.
Thermo Fisher Partners with ALPCO-GeneProof to Broaden Their CE-IVD Molecular Assay Portfolio
ALPCO-GeneProof, a global leader in diagnostics, and Thermo Fisher announced a strategic partnership that brings the TaqPath Menu | GeneProof PCR kits to market. The partnership combines the strengths of ALPCO-GeneProof’s expertise in molecular diagnostics with Thermo Fisher’s robust... - April 17, 2023 - ALPCO
DistillerSR Appoints New Board Members to Accelerate Scaleup and Healthcare Analytics Domain Expertise
DistillerSR® Inc., the market leader in AI-enabled literature review automation software and creator of DistillerSR™, today welcomed Dr. Khaled El Emam and Jason Flick as new board members. The two serial entrepreneurs join Andrew Pinkerton, Partner at Thomvest Ventures, Maria Pacella,... - April 11, 2023 - DistillerSR
New Collagen for Skin and Beauty | Fitness Researchers May Shift Beauty Care Towards Advanced Sports Methods
Newly formulated collagen for fitness lifts the anti-aging and natural-beauty effects simultaneously. Vigor™, a health and fitness nutrition company specializing in bodybuilding proteins, has led the development. Sports proteins have always been at the forefront of nutritional innovation, yet, collagen is a protein type that only recently entered gym routines. Researchers have unveiled its benefit to the full extent for the first time. - April 11, 2023 - Vigor LLC
Distinguished RN Joins the 910AM Superstation Radio Host Lineup as the First Registered Nurse Through Her New Talk Radio Show "Nurse Charms LIVE"
Charmaine Bond AKA “Nurse Charms” is launching her new, trending, radio talk show in celebration of her brand “Nurse Charms”®️ becoming a Registered Trademark. Nurse Charms has spent over 20 years in her nursing career with a passion and dedication for helping... - April 10, 2023 - Nurse Charms
Dr. V. Kim Kutsch Releases New Podcast, "Contrary to Ordinary"
On March 21, 2023 Dr. V. Kim Kutsch, CEO of Oral BioTech and founder of CariFree, released a podcast titled “Contrary to Ordinary.” Dr. Kutsch aims to uncover the common threads that make people extraordinary. Each bi-weekly episode will showcase a thought leader in the dental industry... - March 30, 2023 - Oral BioTech
HSG and HD-CAB Collaborate to Provide Global Patient Advisory Board
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease (HD), recently collaborated with Huntington’s Disease – Community Advisory Board (HD-CAB) to provide a... - March 30, 2023 - Huntington Study Group
New Research on Decentralized Clinical Trial (DCT) Strategies to Boost Patient Diversity
Current and Future Clinical Trial Participants Link Enhanced Diversity and Inclusion of Underrepresented Patient Populations to DCT - March 29, 2023 - Life Science Strategy Group, LLC
A New Philosophy for Jamaican Pot
Massive Therapeutics, a medical cannabis company, has released its list of the most important reasons organic farming techniques should be implemented over non-organic. Cannabis has a long history, from its use in traditional medicine to its current status as a lucrative crop. In Jamaica, the... - March 27, 2023 - Massive Therapeutics
HSG Announces 30th Annual Meeting
The Huntington Study Group (HSG), a world leader in conducting clinical trials and providing educational programming for Huntington’s disease (HD), recently announced that their 2023 Annual Meeting will be held November 2-4, 2023 at the Sheraton Grand at Wild Horse Pass in Chandler, AZ, a... - March 21, 2023 - Huntington Study Group
Gallant Deepens Its Bench by Adding Dr. Valentine Williams as Senior Vice President of Clinical Development and Regulatory
Furthering its mission to bring regenerative medicine to all pets, animal biotech company Gallant Therapeutics welcomes an industry leader, Dr. Val Williams, to its pioneering team. - March 17, 2023 - Gallant
New Research Identifies Latest Clinical Development and CRO Outsourcing Trends in China
Groundbreaking Research Explores the Chinese Innovative Biopharmaceutical Clinical Development Market, CRO Outsourcing and Future Growth with Over 100 Chinese Biopharma Professionals - March 15, 2023 - Life Science Strategy Group, LLC
Dr. Ainhoa de Federico to Receive Honorary Doctorate; International Award Recognizes Achievements in Natural Vision and Holistic Health & Healing
Creator of the ClearSight Method of natural vision improvement, Dr. Ainhoa de Federico is one of the world’s leading holistic natural vision educators. Her dedication to research, education, teaching and social impact has had a profound impact on the lives of countless individuals in more than 200 countries, and her work has inspired many in the health and wellness community. - March 14, 2023 - Dr. Ainhoa de Federico
GENINVO Launches Its Latest Offering – Datalution
GenInvo, a leading provider of life science product and business solutions announced the launch of its new, on-demand service: Datalution. GenInvo has recognized various challenges the pharmaceutical industry faces, especially in generating data for clinical trials. The need of clinical data to... - March 11, 2023 - GenInvo, Inc.
Nuvi Global Congratulates Julio Chavez's Promotion
Julio’s Promotion is a sure sign of a successful win within Nuvi Global for now and for the future. - February 23, 2023 - Nuvi Global
Nuvi Global Reveals Weight Management Line
Ontario, California-based wellness unveils a new and effective weight management line to see everyone be their best possible self. - February 23, 2023 - Nuvi Global
North Texas Plastic Surgery to Offer Semaglutide Weight Loss Treatment
The biggest advancement in weight loss treatment is now being offered at North Texas Plastic Surgery in Dallas. - February 17, 2023 - North Texas Plastic Surgery
DistillerSR Launches Industry's Most Comprehensive and Configurable PRISMA 2020 Flow Diagram Reporting Module
DistillerSR® Inc., the market leader in AI-enabled literature review automation software and creator of DistillerSR™, today announced the launch of full support for the PRISMA 2020 report guidelines. DistillerSR’s PRISMA 2020 flow diagram reporting module enables research... - January 31, 2023 - DistillerSR
Ascend Imaging Center in Southfield, Michigan is Offering Free Calcium Score in Honor of February's "American Heart Month"
Ascend Imaging is offering a Free Calcium Score in honor of American Heart Month for the Month of February, leveraging the latest Artificial Intelligence and technology for the 21st century for the nation's #1 killer, heart attacks. - January 31, 2023 - Ascend Imaging Center
Careington Proud to Sponsor 13th Annual Dr. Martin Luther King Jr. Essay and Oration Scholarship Competition
Careington is proud to have served another year as a "Dream" level sponsor for the 13th annual Dr. Martin Luther King Jr. Essay and Oration Scholarship competition. This annual event is hosted by Linking Cultures of Frisco, a Frisco-based non-profit organization with a mission to connect... - January 29, 2023 - Careington
David Joseph Joins XeroThera as President
XeroThera, Inc, a privately held biomaterials and med tech company, developing breakthrough technologies for tissue engineering and the controlled and targeted delivery of drugs and biological molecules, today announced that David S. Joseph has joined the company as President. He is also joining... - January 18, 2023 - XeroThera
Genesis AEC Celebrates 25th Anniversary
Leading AEC firm’s milestone includes 8,300+ projects for 600+ life sciences leaders nationwide. - January 18, 2023 - Genesis AEC
Newly Available Horse-Side IgG Test Requires No Refrigeration
VMRD, Inc is excited to share the launch of their latest offering for equine veterinarians, a novel horse-side test to measure IgG in foals. - January 17, 2023 - VMRD, Inc.
NooIQ™: Premium "Min-Stim" Nootropic Adaptogen Supplement Stack for Memory and Learning
NooIQ™ is a premium nootropic multi-supplement capsule based on an exhaustive literature review and 7 years of rigorous R&D. Ingredients such as Choline (CDP and Bitartrate) and Magnesium (Citrate and L-threonate) are often associated with improved memory and learning. Others such as L-theanine support concentration and focus while avoiding the excess stimulants found in nervous-energy producing products such as energy shots, as per the manufacturer's minimally-stimulant ("Min-Stim") philosophy. - January 14, 2023 - Integrity Nootropics
Huntington Study Group Names First Chief Innovation Officer
The Huntington Study Group (HSG), a world leader in clinical research for Huntington’s Disease (HD) for over 30 years, today announced Brett Kinsler has been named to the newly created position of Chief Innovation Officer (CINO). - January 10, 2023 - Huntington Study Group
David Roh Joins AeroGo, Inc. as Western Regional Sales Manager
AeroGo, Inc. is pleased to announce that David Roh has joined the firm as Western Regional Sales Manager. David will manage business relationships and dealer development throughout the western half of the United States and Canada. David will focus on flexible manufacturing solutions and provide... - January 03, 2023 - AeroGo, Inc.
Nisha Johari, MD & Co-Founder, JDHL Featured as "Most Influential Business-Woman of the Year 2022"
Mrs Nisha Johari, MD & Co-founder of Johari Digital Healthcare Ltd. has been featured as "The Most Influential Business Women of the Year 2022,” by The CEO Magazine. - December 31, 2022 - Johari Digital Healthcare Ltd.
The Catholic Children’s Home Receives a Christmas Surprise
ProCare Health Embraces the Gift of Giving - December 23, 2022 - ProCare Health
Paras Biopharmaceuticals Creates Excellence with “Continuous Biomanufacturing”: Achieves Objectives of “High Productivity & Biomanufacturing Innovation”
With 6 years of dedicated work at Paras Biopharmaceuticals and the use of Paras Biopharmaceuticals’ unique technology platform (which comprises of Bioproduction technologies for economical production of biologics), the company is pleased to announce that an excellent scale-up production process is achieved with “Continuous Biomanufacturing.” - December 19, 2022 - Paras Biopharmaceuticals Finland Oy
Paras Biopharma Streamlines Offerings as “Biologics CDMO” and Biosimilar Co-Development as “Paras Biologics”
Paras Biopharmaceuticals Finland Oy today revealed that the company has streamlined and enhanced its business activities with the establishment of a division called, Paras Biologics. In addition to its existing biologics CDMO activities and capabilities (this division is now referred to as Paras Biopharma), the creation of Paras Biologics enhances the company’s biologics and biosimilar pipeline for co-development and licensing opportunities. - December 11, 2022 - Paras Biopharmaceuticals Finland Oy
PharmStars Announces Fall 2022 Accelerator Graduates: 11 Digital Health Startups Complete PharmStars’ Pharma-Focused Accelerator Program
PharmStars, the pharma-focused accelerator for digital health startups, announces the graduation of 11 startups from its Fall 2022 program focused on “Innovations in Real-World Evidence.” The graduating startups successfully completed PharmaU, PharmStars’ 10-week education, and mentoring program. PharmaU culminated with a Showcase Event--held in Boston in early November--that brought together the participating startups and PharmStars’ seven innovation-minded pharma members. - December 08, 2022 - PharmStars
IVL Creates New Supplement for Optimized Nitric Oxide Support and Better Blood Flow
4 ingredients to support the body's production of Nitric Oxide, a vital molecule for maintaining healthy muscles and blood vessels. - December 08, 2022 - IVL.com
PharmStars Announces “Innovations in Women’s Health and Health Equity” Theme for Spring 2023 Accelerator
PharmStars, the pharma-focused accelerator for digital health startups, is now accepting applications for its Spring 2023 cohort with the theme “Digital Innovations in Women’s Health and Health Equity.” Startups with digital innovations that promote more equitable, inclusive healthcare for underserved population or focused on women’s health (e.g., breast, ovarian, and cervical cancer; gynecological conditions; osteoporosis; menopausal, hormonal, and reproductive conditions) are welcome to apply. - December 05, 2022 - PharmStars